Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Rational design of a novel peripherally-restricted, orally active CB(1) cannabinoid antagonist containing a 2,3-diarylpyrrole motif.

Hortala L, Rinaldi-Carmona M, Congy C, Boulu L, Sadoun F, Fabre G, Finance O, Barth F.

Bioorg Med Chem Lett. 2010 Aug 1;20(15):4573-7. doi: 10.1016/j.bmcl.2010.06.017. Epub 2010 Jun 8.

PMID:
20584609
2.

[Pharmacology of cannabinoid receptors].

Le Fur G, Rinaldi-Carmona M, Barth F, Alexander J.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):933-8; discussion 938-40. French.

PMID:
18225447
3.

Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.

Cui YY, D'Agostino B, Risse PA, Marrocco G, Naline E, Zhang Y, Chen HZ, Finance O, Rinaldi-Carmona M, Rossi F, Advenier C.

Eur J Pharmacol. 2007 Nov 14;573(1-3):206-13. Epub 2007 Jul 3.

PMID:
17643417
4.

Different pharmacological profile of two closely related endocannabinoid ester analogs.

Bobrov M, Gretskaya N, Payet O, Bezuglov V, Durand T, Maurin L, Tourrel F, Adjali O, Rinaldi-Carmona M, Muller A.

Life Sci. 2005 Aug 12;77(13):1425-40.

PMID:
15894337
5.

SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization.

Rinaldi-Carmona M, Barth F, Congy C, Martinez S, Oustric D, Pério A, Poncelet M, Maruani J, Arnone M, Finance O, Soubrié P, Le Fur G.

J Pharmacol Exp Ther. 2004 Sep;310(3):905-14. Epub 2004 May 6.

PMID:
15131245
6.

Carbon-11 labeled radioligands for imaging brain cannabinoid receptors.

Mathews WB, Scheffel U, Rauseo PA, Ravert HT, Frank RA, Ellames GJ, Herbert JM, Barth F, Rinaldi-Carmona M, Dannals RF.

Nucl Med Biol. 2002 Aug;29(6):671-7.

PMID:
12234592
7.

Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.

Landi M, Croci T, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Manara L.

Eur J Pharmacol. 2002 Aug 16;450(1):77-83.

PMID:
12176112
8.

Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon.

Manara L, Croci T, Guagnini F, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Mukenge S, Ferla G.

Dig Liver Dis. 2002 Apr;34(4):262-9.

PMID:
12038810
9.

Biodistribution of [18F] SR144385 and [18F] SR147963: selective radioligands for positron emission tomographic studies of brain cannabinoid receptors.

Mathews WB, Scheffel U, Finley P, Ravert HT, Frank RA, Rinaldi-Carmona M, Barth F, Dannals RF.

Nucl Med Biol. 2000 Nov;27(8):757-62.

PMID:
11150708
10.

Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.

Gouldson P, Calandra B, Legoux P, Kernéis A, Rinaldi-Carmona M, Barth F, Le Fur G, Ferrara P, Shire D.

Eur J Pharmacol. 2000 Jul 28;401(1):17-25.

PMID:
10915832
11.

The development of cannabinoid antagonists.

Barth F, Rinaldi-Carmona M.

Curr Med Chem. 1999 Aug;6(8):745-55. Review.

PMID:
10469889
12.

Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.

Shire D, Calandra B, Bouaboula M, Barth F, Rinaldi-Carmona M, Casellas P, Ferrara P.

Life Sci. 1999;65(6-7):627-35. Review.

PMID:
10462063
13.

SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.

Portier M, Rinaldi-Carmona M, Pecceu F, Combes T, Poinot-Chazel C, Calandra B, Barth F, le Fur G, Casellas P.

J Pharmacol Exp Ther. 1999 Feb;288(2):582-9.

PMID:
9918562
14.

In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum.

Croci T, Manara L, Aureggi G, Guagnini F, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Mukenge S, Ferla G.

Br J Pharmacol. 1998 Dec;125(7):1393-5.

15.

Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system.

Rinaldi-Carmona M, Le Duigou A, Oustric D, Barth F, Bouaboula M, Carayon P, Casellas P, Le Fur G.

J Pharmacol Exp Ther. 1998 Dec;287(3):1038-47.

PMID:
9864290
16.

The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.

Derocq JM, Bouaboula M, Marchand J, Rinaldi-Carmona M, Ségui M, Casellas P.

FEBS Lett. 1998 Apr 3;425(3):419-25.

17.

SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.

Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Brelière JC, Le Fur GL.

J Pharmacol Exp Ther. 1998 Feb;284(2):644-50.

PMID:
9454810
18.

A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions.

Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, Maffrand JP, Le Fur G, Casellas P.

J Biol Chem. 1997 Aug 29;272(35):22330-9.

19.

Characterization of CB1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR 141716A.

Jung M, Calassi R, Rinaldi-Carmona M, Chardenot P, Le Fur G, Soubrié P, Oury-Donat F.

J Neurochem. 1997 Jan;68(1):402-9.

20.

Characterization of two cloned human CB1 cannabinoid receptor isoforms.

Rinaldi-Carmona M, Calandra B, Shire D, Bouaboula M, Oustric D, Barth F, Casellas P, Ferrara P, Le Fur G.

J Pharmacol Exp Ther. 1996 Aug;278(2):871-8.

PMID:
8768742
21.

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.

Terranova JP, Storme JJ, Lafon N, Péŕio A, Rinaldi-Carmona M, Le Fur G, Soubrié P.

Psychopharmacology (Berl). 1996 Jul;126(2):165-72.

PMID:
8856836
22.

Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor.

Shire D, Calandra B, Rinaldi-Carmona M, Oustric D, Pessègue B, Bonnin-Cabanne O, Le Fur G, Caput D, Ferrara P.

Biochim Biophys Acta. 1996 Jun 7;1307(2):132-6.

PMID:
8679694
23.

Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.

Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrié B, Rinaldi-Carmona M, Calandra B, Le Fur G, Casellas P.

Eur J Biochem. 1996 May 1;237(3):704-11.

24.

Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A.

Pério A, Rinaldi-Carmona M, Maruani J, Barth F, Le Fur G, Soubrié P.

Behav Pharmacol. 1996 Jan;7(1):65-71.

PMID:
11224395
25.

Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.

Rinaldi-Carmona M, Pialot F, Congy C, Redon E, Barth F, Bachy A, Brelière JC, Soubrié P, Le Fur G.

Life Sci. 1996;58(15):1239-47.

PMID:
8614277
26.

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.

Bouaboula M, Poinot-Chazel C, Bourrié B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G, Casellas P.

Biochem J. 1995 Dec 1;312 ( Pt 2):637-41.

27.

The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat.

Gueudet C, Santucci V, Rinaldi-Carmona M, Soubrié P, Le Fur G.

Neuroreport. 1995 Jul 10;6(10):1421-5.

PMID:
7488739
28.

Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells.

Bouaboula M, Bourrié B, Rinaldi-Carmona M, Shire D, Le Fur G, Casellas P.

J Biol Chem. 1995 Jun 9;270(23):13973-80.

29.

Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice.

Souilhac J, Poncelet M, Rinaldi-Carmona M, Le Fur G, Soubrié P.

Pharmacol Biochem Behav. 1995 May;51(1):3-7.

PMID:
7617730
30.

An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing.

Shire D, Carillon C, Kaghad M, Calandra B, Rinaldi-Carmona M, Le Fur G, Caput D, Ferrara P.

J Biol Chem. 1995 Feb 24;270(8):3726-31. Erratum in: J Biol Chem 1996 Dec 27;271(52):33706.

31.

Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.

Rinaldi-Carmona M, Barth F, Héaulme M, Alonso R, Shire D, Congy C, Soubrié P, Brelière JC, Le Fur G.

Life Sci. 1995;56(23-24):1941-7.

PMID:
7776817
32.

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.

Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, et al.

FEBS Lett. 1994 Aug 22;350(2-3):240-4.

33.

Regulation of 5-hydroxytryptamine2 (5-HT2) receptor expression in cultured rat aortic smooth muscle cells by SR 46349B, a selective 5-HT2 receptor antagonist.

Rinaldi-Carmona M, Prabonnaud V, Bouaboula M, Poinot-Chazel C, Casellas P, Le Fur G, Herbert JM.

J Biol Chem. 1994 Jan 7;269(1):396-401.

34.

Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brain.

Rinaldi-Carmona M, Congy C, Pointeau P, Vidal H, Brelière JC, Le Fur G.

Life Sci. 1994;54(2):119-27.

PMID:
8277817
35.

Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist.

Rinaldi-Carmona M, Bouaboula M, Congy C, Oury-Donat F, Simiand J, Shire D, Casellas P, Soubrié P, Brelière JC, Le Fur G.

Eur J Pharmacol. 1993 Jun 15;246(1):73-80.

PMID:
8354344
36.

Repeated administration of SR 46349B, a selective 5-hydroxytryptamine2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain.

Rinaldi-Carmona M, Congy C, Simiand J, Oury-Donat F, Soubrie P, Breliere JC, Le Fur G.

Mol Pharmacol. 1993 Jan;43(1):84-9.

PMID:
8423772
37.

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.

Rinaldi-Carmona M, Congy C, Santucci V, Simiand J, Gautret B, Neliat G, Labeeuw B, Le Fur G, Soubrie P, Breliere JC.

J Pharmacol Exp Ther. 1992 Aug;262(2):759-68.

PMID:
1501121
38.

Interaction of SR 33557 with skeletal muscle calcium channel blocker receptors in the baboon: characterization of its binding sites.

Sol-Rolland J, Joseph M, Rinaldi-Carmona M.

J Pharmacol Exp Ther. 1991 May;257(2):595-602.

PMID:
1851830

Supplemental Content

Loading ...
Support Center